Exploration of Neuroprotective Therapy

Open Access Retraction

Retraction: Diffusion magnetic resonance imaging-based surrogate marker in amyotrophic lateral sclerosis

Editorial Office

Published: December 29, 2023 Explor Neuroprot Ther. 2023;3:513

DOI: https://doi.org/10.37349/ent.2023.00066

Full Text PDF

1072 35 0

Open Access Review

Breaking the amyotrophic lateral sclerosis early diagnostic barrier: the promise of general markers

Yizhou Lu ... Qinming Zhou

Published: December 27, 2023 Explor Neuroprot Ther. 2023;3:497–512

DOI: https://doi.org/10.37349/ent.2023.00065

Full Text PDF

2861 63 0

Open Access Original Article

Effects of acoustic neurostimulation in healthy adults on symptoms of depression, anxiety, stress and sleep quality: a randomized clinical study

Sandro A. Kanzler ... Rui Daniel Prediger

Published: December 26, 2023 Explor Neuroprot Ther. 2023;3:481–496

DOI: https://doi.org/10.37349/ent.2023.00064

Full Text PDF

5267 121 1

Open Access Systematic Review

Effectiveness of dry needling on the treatment of patients with multiple sclerosis: systematic review

Ali Mutlu ... Buket Büyükturan

Published: December 26, 2023 Explor Neuroprot Ther. 2023;3:470–480

DOI: https://doi.org/10.37349/ent.2023.00063

This article belongs to the special issue Dry Needling for Neurological Disorders

Full Text PDF

2548 65 1

Open Access Case Report

Hyperbaric oxygen therapy—a new hope for Alzheimer’s patients: a case report and literature review

Elizabeta B. Mukaetova-Ladinska ... Qadeer Arshad

Published: December 22, 2023 Explor Neuroprot Ther. 2023;3:457–469

DOI: https://doi.org/10.37349/ent.2023.00062

This article belongs to the special issue Defending the Brain and the Mind: Exploring Neuroprotective Therapies for Mental Health Disorders

Full Text PDF

11352 98 1

Open Access Original Article

Minimum spanning tree analysis for epilepsy magnetoencephalography (MEG) data

Sunhan Shin ... Jaehee Kim

Published: December 13, 2023 Explor Neuroprot Ther. 2023;3:446–456

DOI: https://doi.org/10.37349/ent.2023.00061

Full Text PDF

1992 33 1

Open Access Original Article

Unique cerebrospinal fluid peptides: potential amyotrophic lateral sclerosis biomarkers and etiological factors

Uri Wormser ... Yoram Finkelstein

Published: December 12, 2023 Explor Neuroprot Ther. 2023;3:435–445

DOI: https://doi.org/10.37349/ent.2023.00060

Full Text PDF

1882 36 1

Open Access Commentary

Further arguments in favor of the biological relevance of purinergic receptors: the novel emergence of a purinergic signature

Cinzia Volonté, Rafael Franco

Published: November 29, 2023 Explor Neuroprot Ther. 2023;3:429–434

DOI: https://doi.org/10.37349/ent.2023.00059

Full Text PDF

1292 22 0

Open Access Review

From the ocean to the brain: harnessing the power of marine algae for neuroprotection and therapeutic advances

Leonel Pereira, Ana Valado

Published: November 17, 2023 Explor Neuroprot Ther. 2023;3:409–428

DOI: https://doi.org/10.37349/ent.2023.00058

This article belongs to the special issue Natural Products in Neurotherapeutic Applications

Full Text PDF

6848 150 2